Clinicopathological comparisons of familial and sporadic cases in 219 consecutive Japanese epithelial ovarian cancer patients

Japanese Journal of Clinical Oncology

Volumn 29, Issue 11, 1999, Pages 556-561

  Sagawa, Tadashi ^a   Yamashita, Yoichiro ^a   Fujimoto, Toshio ^a   Yamada, Hideto ^a   Hoshi, Nobuhiko ^a   Sakuragi, Noriaki ^a   Fujimoto, Seiichiro ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Breast ovarian cancer syndrome; Epithelial ovarian cancer; Familial ovarian cancer; Hereditary nonpolyposis colorectal cancer

Indexed keywords

ARTICLE; ASIAN; BREAST TUMOR; CARCINOMA; COMPARATIVE STUDY; FEMALE; GENETICS; HUMAN; JAPAN; MORTALITY; MULTIPLE CANCER; OVARY TUMOR; PATHOLOGY; PEDIGREE; PROGNOSIS; SURVIVAL RATE;

ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CARCINOMA; FEMALE; HUMANS; JAPAN; NEOPLASMS, MULTIPLE PRIMARY; OVARIAN NEOPLASMS; PEDIGREE; PROGNOSIS; SURVIVAL RATE;

EID: 0033218075     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/29.11.556     Document Type: Review

References (35)

1. Lynch HT, Conway T, Lynch J. Hereditary ovarian cancer. In: Sharp F, Mason WP, Leake RE, editors. Ovarian Cancer: Biological and Therapeutic Challenges. Chapman and Hall Medical, Cambridge, 1990;7-19.
2. Boyd J. Molecular genetics of hereditary ovarian cancer. Oncology 1998;12:399-406.
3. Liede A, Tonin PN, Sun CC Serruya C, Daly MB, Narod SA, et al. Is hereditary site-specific ovarian cancer a distinct genetic condition? Am J Med Genet 1998;75:55-8.
4. Bewtra C, Watson P, Conway T, Read-Hipee C, Lynch HT. Hereditary ovarian cancer: a clinicopathological study. Int J Gynecol Pathol 1992;11:180-7.
5. Piver MS, Baker TR, Jishi MF, Sandecki AM, Tsukada Y, Natarajan N, et al. Familial ovarian cancer. A report of 658 families from the Gilda Radner familial ovarian cancer registry 1981-1991. Cancer 1993;71:582-8.
6. Greggi S, Ponder BAJ, Mancuso S. Establishment of a European registry for familial ovarian cancer. Eur J Cancer 1991;27:113-5.
7. Ichikawa Y, Nishida M, Sugita M, Arisawa Y, Satoh T, Oki A, et al. Analysis of familial aggregation of ovarian and breast cancer in patients with ovarian cancer. Nippon Sanka Fujinka Gakkai Zasshi 1995;47:901-6 (in Japanese).
8. Takano M, Aida H, Tsuneki I, Takakuwa K, Hasegawa I, Tanaka H, et al. Mutational analysis of BRCA1 gene in ovarian and breast-ovarian cancer families in Japan. Jpn J Cancer Res 1997;88:407-13.
9. Aida H, Takakuwa K, Nagata H, Tsuneki I, Takano M, Tsuji S, et al. Clinical features of ovarian cancer in Japanese women with germ-line mutations of BRCA1. Clin Cancer Res 1998;4:235-40.
10. Shimizu Y, Kamoi S, Amada S, Akiyama F, Silverberg SG. Toward the development of a universal grading system for ovarian epithelial carcinoma. Testing of a proposed system in a series of 461 patients with uniform treatment and follow-up. Cancer 1998;82:893-901.
11. Narod SA, Madlensky L, Bradley L, Cole D, Tonin P, Rosen B, et al. Hereditary and familial ovarian cancer in Southern Ontario. Cancer 1994;74:2341-6.
12. Greggi S, Genuardi M, Benedetti-Panici P, Cento R, Scambia G, Neri G, et al. Analysis of 138 consecutive ovarian cancer patients: incidence and characteristics of familial cases. Gynecol Oncol 1990;39:300-4.
13. Vasen HFA, Mecklin J-P, Meera Khan P, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424-5.
14. Utsunomiya J, Miyaki M. Studies of hereditary nonpolyposis colorectal cancer in Japan. Int J Clin Oncol 1998;3:53-74.
15. Vasen HFA. What is hereditary non-polyposis colorectal cancer? Anticancer Res 1994;14:1613-6
16. Kunitomo K, Terashima Y, Sasaki K, Komi N, Yoshikawa, R, Utsunomiya J, et al. HNPCC in Japan. Anticancer Res 1992;12:1856-7.
17. Zweemer RP, Verheijen RHM, Gille JJP, van Diest PJ, Pals G, Menko FH, et al. Clinical and genetic evaluation of thirty ovarian cancer families. Am J Obstet Gynecol 1998;178:85-90.
18. Rubin SC, Benjamin I, Behbakht K, Takahashi H, Morgan MA, LiVolsi VA, et al. Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N Engl J Med 1996;335:1413-6.
19. Chang J, Fryatt I, Ponder B, Fisher C, Gore ME. A matched control study of familial epithelial ovarian cancer: patient characteristics, response to chemotherapy and outcome. Ann Oncol 1995;6:80-2.
20. Lynch HT, Watson P, Bewtra C, Conway TA, Hippee CR, Kaur P, et al. Hereditary ovarian cancer. Heterogeneity in age at diagnosis. Cancer 1991;67:1460-6.
21. Lynch HT, Watson P, Lynch JF, Conway TA, Fili M. Hereditary ovarian cancer. Heterogeneity in age at onset. Cancer 1993;71:573-81.
22. Lynch HT, Lanspa S, Smyrk T, Boman B, Watson P, Lynch J. Hereditary nonpolyposis colorectal cancer (Lynch syndrome I & II). Genetics, pathology, natural history and cancer control, part I. Cancer Genet Cytogenet 1991;53:143-60.
23. Lynch HT, Smyrk TC, Watson P, Lanspa SJ, Lynch JF, Lynch PM, et al. Genetics, natural history, tumor spectrum and pathology of hereditary nonpolyposis colorectal cancer: an update review. Gastroenterology 1991;53:143-60.
24. Johannsson OT, Ranstam J, Borg A, Olsson H. Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden. J Clin Oncol 1998;16:397-404.
25. Angioli R, Estape R, Mason M, Penalver M. Hereditary and sporadic ovarian cancer: genetic testing and clinical implication (review). Int J Oncol 1998;12:1029-34.
26. Berchuck A, Carney M, Lancaster JM, Marks J, Futreal AP. Familial breast-ovarian cancer syndromes: BRCA1 and BRCA2. Clin Obstet Gynecol 1998;41:157-66.
27. Takahashi H, Behbakht K, McGovern PE, Chiu H-C, Couch FJ, Weber BL, et al. Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res 1995;55:2998-3002.
28. Hosking L, Trowsdale J, Nicolai H, Solomon E, Foulkes W, Stamp G, et al. A somatic BRCA1 mutation in an ovarian tumour. Nature Genet 1995;9:343-4.
29. Struewing JP, Abeliovich D, Peretz T, Avishai N, Kaback MM, Collins FS, et al. The carrier frequency of the BRCA1 185de1AG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nature Genet 1995;11:198-200.
30. Roa BB, Boyd AA, Volcik R, Richards CS. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nature Genet 1996;14:185-7.
31. Easton DF, Ford D, Bishop DT, Breast Cancer Linkage Consortium. Breast and ovarian cancer incidence in BRCA1-mutation. Am J Hum Genet 1995;56:265-71.
32. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE, Breast Cancer Linkage Consortium. Risks of cancer in BRCA1-mutation carriers. Lancet 1994;343:692-5.
33. Struewing JP, Hartge P, Wacholder S, Baker S, Berlin M, McAdams M, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997;336:1401-8.
34. Narod SA, Goldgar D, Cannon-Albright L, Weber B, Moslehi R, Ives E, et al. Risk modifiers in carriers of BRCA1 mutations. Int J Cancer 1995;64:394-8.
35. Phelan CM, Rebbeck TR, Weber BL, Devilee P, Ruttledge MH, Lynch HT, et al. Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus. Nature Genet 1996;12:309-11.